Today, orthopaedics is still in search for the most reliable biomaterial for prosthesis. The biomaterial needs to have good longevity and other supporting properties in order to maintain low implant failure. An ideal metallic biomaterial should be biocompatible, has similar elastic modulus to that of bone, has excellent resistance to fatigue, corrosion, aseptic loosening, and wear, and has good bone-bonding ability. The success of an implant depends on many factors. Good osseointegration is one of the factors required to reduce the rate of loosening of implants and in order to increase the chance of osseointegration, high stability of implants and early healing process encouragement are needed.

BackgroundChronic renal failure is an important clinical problem with significant socioeconomic impact worldwide. Thoracic spinal cord entrapment induced by a metabolic yield deposit in patients with renal failure results in intrusion of nervous tissue and consequently loss of motor and sensory function. Human umbilical cord mesenchymal stem cells are immune naïve and they are able to differentiate into other phenotypes, including the neural lineage. Over the past decade, advances in the field of regenerative medicine allowed development of cell therapies suitable for kidney repair. Mesenchymal stem cell studies in animal models of chronic renal failure have uncovered a unique potential of these cells for improving function and regenerating the damaged kidney.Case presentationWe report a case of a 62-year-old ethnic Indonesian woman previously diagnosed as having thoracic spinal cord entrapment with paraplegic condition and chronic renal failure on hemodialysis. She had diabetes mellitus that affected her kidneys and had chronic renal failure for 2 years, with creatinine level of 11 mg/dl, and no urinating since then. She was treated with human umbilical cord mesenchymal stem cell implantation protocol. This protocol consists of implantation of 16 million human umbilical cord mesenchymal stem cells intrathecally and 16 million human umbilical cord mesenchymal stem cells intravenously. Three weeks after first intrathecal and intravenous implantation she could move her toes and her kidney improved. Her creatinine level decreased to 9 mg/dl. Now after 8 months she can raise her legs and her creatinine level is 2 mg/dl with normal urinating.ConclusionsHuman umbilical cord mesenchymal stem cell implantations led to significant improvement for spinal cord entrapment and kidney failure. The major histocompatibility in allogeneic implantation is an important issue to be addressed in the future.

Summary Sidestream dark field imaging represents a novel, noninvasive method to study the microcirculation in humans and animals. To‐date, it has been used extensively in various peripheral tissues (e.g. sublingual area, intestinal mucosa), however no data for the ocular vasculature, including the iridial microcirculation, are currently available. Therefore, the aim of this study was to examine the reliability and reproducibility of sidestream dark field imaging within the iridial microcirculation in experimental animals. Male Lewis rats were anaesthetized and the iris microvasculature was observed using an sidestream dark field probe gently placed against a cover slip covering the right eye. All video sequences recorded were analysed off‐line by using AVA 3.0 software (MicroVision Medical, Amsterdam, The Netherlands). Results are expressed as mean (±SE) or median (interquartile range). Clear images were recorded from each animal and the total number of analysable video sequences was 50. All raw data for selected vessel density parameters passed normality test. The total all and small vessel density (in mm mm‐2) were 22,6 (±0,58) and 19,6 (±0,68), respectively. The perfused all and small vessel density were 20,9 (±0,61) and 19,1 (±0,65), respectively. The mean values of all iris vessel density parameters are shown in Figure 4. The DeBacker Score (n/mm) was 15,2 (±0,45), the proportion of perfused vessel was 94,5% (89,8–99,1%), and the MFI was 3 points (3–3). Taken together, these results indicate that SDF imaging provides a reliable and noninvasive method to examine the iridial microvascular bed in vivo and, thus, may provide unique opportunities for the study of the iridial vascular network in various experimental and clinical settings and disease models. 4 Vessel Density. TAVD = Total all vessel density; PAVD = Perfused all vessel density; TSVD = Total small vessel density; PSVD = Perfused small vessel density. Data are shown as a mean (±SE), small vessels are referred to diameter ≤ 25 um.